Pancreatic Cancer Research

ResearcherUniversity of Campania "Luigi Vanvitelli"Active in the last 2 years

Eduardo Ibello

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9308-4690; OpenAlex author ID A5066662336. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Mechanobiology-guided drug repurposing identifies budesonide as an inhibitor of stiffness-induced PDAC aggressiveness Co-author DOI 10.64898/2026.07.17.739125↗
  2. Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolism. Co-author DOI 10.1186/s13046-024-03072-1↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Enza Lonardo · 2 shared papers, 2024–2026 · strength 0.43
  2. Cristina D’Aniello · 2 shared papers, 2024–2026 · strength 0.43
  3. Gabriella Minchiotti · 2 shared papers, 2024–2026 · strength 0.43
  4. Bruno Sáinz · 2 shared papers, 2024–2026 · strength 0.43
  5. Simone Mas · 1 shared paper, 2026 · strength 0.26
  6. Paolo A. Netti · 1 shared paper, 2026 · strength 0.26
  7. Donatella Delle Cave · 1 shared paper, 2024 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.